IRF4 and B-cell non-Hodgkin lymphoma: BCL2 and/or MYC rearrangements are absent and aggressive B-cell lymphomas with IRF4 rearrangement, harboring also MYC and/or BCL2 rearrangements, are excluded from this entity.